Hematology Board
The Specialty Boards and Advisory Committees aim to maintain a composition that reflects the diversity and complexity of the physician and patient populations that certification serves. They include both practicing physician members and public members representing interdisciplinary healthcare professionals, patients and caregivers.
Dr. Gertz is the Roland Seidler Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, Minnesota. He is ABIM Board Certified in Internal Medicine, Hematology and Medical Oncology. Previously, Dr. Gertz served as Treasurer for the International Myeloma Society and President of Mayo Staff Officers and Councilors. He also formerly chaired the Mayo Personnel Committee. He is the Chair of the ABIM Hematology Board.
Dr. Gertz has been recognized as a Mayo Distinguished Clinician and in 2014 received the Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström's Macroglobulinemia. He is recognized for contributions in amyloidosis and Waldenström's macroglobulinemia. He has authored more than 500 peer-reviewed publications in the field and is a frequently invited speaker across the country.
Dr. Gertz is a Master of the American College of Physicians. His undergraduate degree was awarded with highest distinction from Northwestern University, where he graduated Phi Beta Kappa. Dr. Gertz received his medical degree cum laude from Loyola University Chicago’s Stritch School of Medicine in Maywood, Illinois, where he was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago where he was twice voted Resident of the Year.
As of September 2025, Dr. Gertz reported the following external relationships:
Research-related consulting for the following companies, receiving reimbursement for travel expenses and honoraria:
- AbbVie Inc., receiving honoraria.
- Akcea Therapeutics Inc., receiving honoraria.
- Alexion Pharmaceuticals Inc., receiving honoraria.
- AstraZeneca plc, receiving honoraria.
- Alnylam Pharmaceuticals Inc., receiving honoraria.
- DAVA Oncology, receiving honoraria.
- Janssen Pharmaceuticals, receiving honoraria.
- Johnson & Johnson, receiving honoraria.
- Medscape Education, receiving honoraria.
- Sanofi, receiving honoraria.
Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:
- AbbVie Inc., receiving honoraria.
Dr. Gertz is the Roland Seidler Jr. Professor of the Art of Medicine and Chair of the Department of Medicine at the Mayo Clinic in Rochester, Minnesota. He is ABIM Board Certified in Internal Medicine, Hematology and Medical Oncology. Previously, Dr. Gertz served as Treasurer for the International Myeloma Society and President of Mayo Staff Officers and Councilors. He also formerly chaired the Mayo Personnel Committee. He is the Chair of the ABIM Hematology Board.
Dr. Gertz has been recognized as a Mayo Distinguished Clinician and in 2014 received the Jan Waldenström Medal for Medical and Scientific Achievements in Waldenström's Macroglobulinemia. He is recognized for contributions in amyloidosis and Waldenström's macroglobulinemia. He has authored more than 500 peer-reviewed publications in the field and is a frequently invited speaker across the country.
Dr. Gertz is a Master of the American College of Physicians. His undergraduate degree was awarded with highest distinction from Northwestern University, where he graduated Phi Beta Kappa. Dr. Gertz received his medical degree cum laude from Loyola University Chicago’s Stritch School of Medicine in Maywood, Illinois, where he was elected to Alpha Omega Alpha, the medical honor society. He completed a three-year medical residency at Rush-Presbyterian-St. Luke’s Medical Center in Chicago where he was twice voted Resident of the Year.
As of September 2025, Dr. Gertz reported the following external relationships:
Research-related consulting for the following companies, receiving reimbursement for travel expenses and honoraria:
- AbbVie Inc., receiving honoraria.
- Akcea Therapeutics Inc., receiving honoraria.
- Alexion Pharmaceuticals Inc., receiving honoraria.
- AstraZeneca plc, receiving honoraria.
- Alnylam Pharmaceuticals Inc., receiving honoraria.
- DAVA Oncology, receiving honoraria.
- Janssen Pharmaceuticals, receiving honoraria.
- Johnson & Johnson, receiving honoraria.
- Medscape Education, receiving honoraria.
- Sanofi, receiving honoraria.
Service on data and safety monitoring boards for the following companies, with compensation for travel expenses and honoraria:
- AbbVie Inc., receiving honoraria.
Dr. Al Hadidi is an Assistant Professor of Medicine in the Department of Internal Medicine—Division of Hematology and Oncology at the University of Arkansas for Medical Sciences. His research interests include plasma cell dyscrasias and multiple myeloma with a focus on drug development, cellular therapy, immunotherapy, health equity and medical education. He is ABIM Board Certified in Internal Medicine, Medical Oncology and Hematology.
Dr. Al Hadidi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research and the American Society for Transplantation and Cellular Therapy.
Dr. Al Hadidi earned his medical degree from the University of Jordan in Amman, and a Master of Science in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health. Dr. Al Hadidi trained in internal medicine at Hurley Medical Center/Michigan State University and in hematology and oncology at Baylor College of Medicine.
As of May 2026, Dr. Al Hadidi reported no ongoing external relationships.
Dr. Al Hadidi is an Assistant Professor of Medicine in the Department of Internal Medicine—Division of Hematology and Oncology at the University of Arkansas for Medical Sciences. His research interests include plasma cell dyscrasias and multiple myeloma with a focus on drug development, cellular therapy, immunotherapy, health equity and medical education. He is ABIM Board Certified in Internal Medicine, Medical Oncology and Hematology.
Dr. Al Hadidi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research and the American Society for Transplantation and Cellular Therapy.
Dr. Al Hadidi earned his medical degree from the University of Jordan in Amman, and a Master of Science in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health. Dr. Al Hadidi trained in internal medicine at Hurley Medical Center/Michigan State University and in hematology and oncology at Baylor College of Medicine.
As of May 2026, Dr. Al Hadidi reported no ongoing external relationships.
As of March 2026, Mr. Cline reported the following external relationships:
Mr. Cline serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Ohio Health Information Partnership/CliniSync, Community Project Manager, receiving salary support.
- The Southwestern Ohio Hemophilia Foundation, Board President, receiving reimbursement for travel expenses.
As of March 2026, Mr. Cline reported the following external relationships:
Mr. Cline serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- Ohio Health Information Partnership/CliniSync, Community Project Manager, receiving salary support.
- The Southwestern Ohio Hemophilia Foundation, Board President, receiving reimbursement for travel expenses.
Dr. Kurniali is a hematologist and medical oncologist at Sanford Cancer Center in Bismarck, North Dakota, where he has practiced since 2015. He is ABIM Board Certified in Internal Medicine, Hematology and Medical Oncology. He is an Associate Professor of Medicine at the University of North Dakota School of Medicine and Health Sciences and serves as Core Faculty and Director of Research for the Internal Medicine Residency Program at Sanford Health Bismarck/UND.
Dr. Kurniali earned his medical degree from Universitas Trisakti Faculty of Medicine in Jakarta, Indonesia, and also holds a Master of Management degree from Bina Nusantara University Business School. He completed his internal medicine residency at Boston University School of Medicine at Roger Williams Medical Center in Providence, Rhode Island, followed by fellowship training in hematology and oncology at Michigan State University. His academic interests include gastrointestinal malignancies, immunotherapy, biomarkers, clinical research, artificial intelligence and medical education.
Dr. Kurniali is a Fellow of the American College of Physicians and has received multiple recognitions for clinical care, teaching and research, including Sanford Health's Doctors' Doctor Award.
As of March 2026, Dr. Kurniali reported the following external relationships:
- Dr. Kurniali is founder and owner of Let's Play N Grow, a pediatric behavioral therapy center serving children with autism in Dallas.
Dr. Kurniali is a hematologist and medical oncologist at Sanford Cancer Center in Bismarck, North Dakota, where he has practiced since 2015. He is ABIM Board Certified in Internal Medicine, Hematology and Medical Oncology. He is an Associate Professor of Medicine at the University of North Dakota School of Medicine and Health Sciences and serves as Core Faculty and Director of Research for the Internal Medicine Residency Program at Sanford Health Bismarck/UND.
Dr. Kurniali earned his medical degree from Universitas Trisakti Faculty of Medicine in Jakarta, Indonesia, and also holds a Master of Management degree from Bina Nusantara University Business School. He completed his internal medicine residency at Boston University School of Medicine at Roger Williams Medical Center in Providence, Rhode Island, followed by fellowship training in hematology and oncology at Michigan State University. His academic interests include gastrointestinal malignancies, immunotherapy, biomarkers, clinical research, artificial intelligence and medical education.
Dr. Kurniali is a Fellow of the American College of Physicians and has received multiple recognitions for clinical care, teaching and research, including Sanford Health's Doctors' Doctor Award.
As of March 2026, Dr. Kurniali reported the following external relationships:
- Dr. Kurniali is founder and owner of Let's Play N Grow, a pediatric behavioral therapy center serving children with autism in Dallas.
Ms. Lillie is an Advanced Oncology Certified Nurse Practitioner specializing in malignant hematology. Currently, she serves as a Hematology Medical Science Liaison at Natera, where she acts as a strategic bridge between cutting-edge molecular diagnostics and the clinical management of hematologic malignancies. In this role, she translates complex genomic data into actionable clinical insights and supports the integration of circulating tumor DNA (ctDNA) into standard clinical practice.
Prior to joining Natera, Ms. Lillie was a Nurse Practitioner at Inova Schar Cancer Institute in Fairfax, Virginia, where she worked in an outpatient clinic managing patients with leukemia and lymphoma. She began her career working as a bedside nurse on a complex hematology/oncology/stem cell transplant unit at Medstar Georgetown University Hospital in Washington, D.C., after graduating with distinction from the University of Virginia with her Bachelor of Science in Nursing. She was awarded the title "Nurse of the Year" in 2018, nominated by her peers.
Ms. Lillie earned her Master of Science in Nursing from George Mason University, where she was a recipient of the HRSA-sponsored Advancing Nursing Education Workforce Fellowship. This fellowship allowed her to dedicate clinical rotations to serving uninsured and refugee populations. She is board-certified as a Family Nurse Practitioner by the American Association of Nurse Practitioners.
As of December 2025, Ms. Lillie reported the following external relationships:
- Ms. Lillie reported she is the medical science liaison of Natera.
Ms. Lillie is an Advanced Oncology Certified Nurse Practitioner specializing in malignant hematology. Currently, she serves as a Hematology Medical Science Liaison at Natera, where she acts as a strategic bridge between cutting-edge molecular diagnostics and the clinical management of hematologic malignancies. In this role, she translates complex genomic data into actionable clinical insights and supports the integration of circulating tumor DNA (ctDNA) into standard clinical practice.
Prior to joining Natera, Ms. Lillie was a Nurse Practitioner at Inova Schar Cancer Institute in Fairfax, Virginia, where she worked in an outpatient clinic managing patients with leukemia and lymphoma. She began her career working as a bedside nurse on a complex hematology/oncology/stem cell transplant unit at Medstar Georgetown University Hospital in Washington, D.C., after graduating with distinction from the University of Virginia with her Bachelor of Science in Nursing. She was awarded the title "Nurse of the Year" in 2018, nominated by her peers.
Ms. Lillie earned her Master of Science in Nursing from George Mason University, where she was a recipient of the HRSA-sponsored Advancing Nursing Education Workforce Fellowship. This fellowship allowed her to dedicate clinical rotations to serving uninsured and refugee populations. She is board-certified as a Family Nurse Practitioner by the American Association of Nurse Practitioners.
As of December 2025, Ms. Lillie reported the following external relationships:
- Ms. Lillie reported she is the medical science liaison of Natera.
Dr. May is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham (UAB). She specializes in caring for patients with thrombosis and coagulation disorders and is the Physician Advisor for Hemostatic and Antithrombotic Stewardship for UAB Medicine. Dr. May is a board member of the Anticoagulation Forum and an active member of the American Society of Hematology, currently serving on the Committee on Quality. She is also an active medical educator, including roles within UAB's medical school, internal medicine residency and fellowship programs.
She completed her medical degree at Washington University School of Medicine in St. Louis and completed Internal Medicine residency, chief residency and a hematology-oncology fellowship at UAB. She is ABIM Board Certified in Internal Medicine, Medical Oncology and Hematology.
As of May 2026, Dr. May reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:
- CSL Behring, for a Delphi Consensus Panel on Anticoagulation Reversal, receiving honoraria.
Dr. May is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham (UAB). She specializes in caring for patients with thrombosis and coagulation disorders and is the Physician Advisor for Hemostatic and Antithrombotic Stewardship for UAB Medicine. Dr. May is a board member of the Anticoagulation Forum and an active member of the American Society of Hematology, currently serving on the Committee on Quality. She is also an active medical educator, including roles within UAB's medical school, internal medicine residency and fellowship programs.
She completed her medical degree at Washington University School of Medicine in St. Louis and completed Internal Medicine residency, chief residency and a hematology-oncology fellowship at UAB. She is ABIM Board Certified in Internal Medicine, Medical Oncology and Hematology.
As of May 2026, Dr. May reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with compensation for travel expenses and honoraria:
- CSL Behring, for a Delphi Consensus Panel on Anticoagulation Reversal, receiving honoraria.
Dr. Rozell is a medical oncologist at Affiliated Oncologists in Chicago Ridge, Illinois, affiliated with Advocate Christ Medical Center and Advocate South Suburban Hospital. She is ABIM Board Certified in Internal Medicine, Medical Oncology and Hematology.
Dr. Rozell received a medical degree from Northwestern University Medical School. She completed internal medicine training at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota, and hematology-oncology fellowship training at the McGaw Medical Center of Northwestern University.
As of May 2026, Dr. Rozell reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with honoraria:
- AstraZeneca
- Gilead
Dr. Rozell is a medical oncologist at Affiliated Oncologists in Chicago Ridge, Illinois, affiliated with Advocate Christ Medical Center and Advocate South Suburban Hospital. She is ABIM Board Certified in Internal Medicine, Medical Oncology and Hematology.
Dr. Rozell received a medical degree from Northwestern University Medical School. She completed internal medicine training at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota, and hematology-oncology fellowship training at the McGaw Medical Center of Northwestern University.
As of May 2026, Dr. Rozell reported the following external relationships:
Service on a research-related expert panel or advisory board for the following companies, with honoraria:
- AstraZeneca
- Gilead
Dr. Sosa is an Associate Professor at Fox Chase Cancer Center and Disease Site Chief for the Hematology Group. Her clinical interests include consultative hematology with a focus on myeloproliferative disorders, bleeding/thrombosis and anemia. She also has an interest in medical education and has participated extensively in programs and materials to improve and enhance the experience of trainees in the medical sciences.
Dr. Sosa graduated with a Bachelor of Arts in Psychology from Tulane University and a Master of Science in Zoology and Physiology from Louisiana State University. She holds a Doctorate of Medicine/Doctorate of Philosophy from the University of Minnesota in Minneapolis. Dr. Sosa completed her postgraduate training in internal medicine and hematology/oncology at Vanderbilt University, where she trained under the mentorship of John Oates in clinical pharmacology.
As of October 2025, Dr. Sosa reported the following external relationships:
Dr. Sosa serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American Society of Hematology, member, mentor and lecturer, Classical Hematology Mentorship Program Educational Committee, donating stipend back to the American Society of Hematology.
Dr. Sosa is an Associate Professor at Fox Chase Cancer Center and Disease Site Chief for the Hematology Group. Her clinical interests include consultative hematology with a focus on myeloproliferative disorders, bleeding/thrombosis and anemia. She also has an interest in medical education and has participated extensively in programs and materials to improve and enhance the experience of trainees in the medical sciences.
Dr. Sosa graduated with a Bachelor of Arts in Psychology from Tulane University and a Master of Science in Zoology and Physiology from Louisiana State University. She holds a Doctorate of Medicine/Doctorate of Philosophy from the University of Minnesota in Minneapolis. Dr. Sosa completed her postgraduate training in internal medicine and hematology/oncology at Vanderbilt University, where she trained under the mentorship of John Oates in clinical pharmacology.
As of October 2025, Dr. Sosa reported the following external relationships:
Dr. Sosa serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American Society of Hematology, member, mentor and lecturer, Classical Hematology Mentorship Program Educational Committee, donating stipend back to the American Society of Hematology.